Drug: Botulinum toxin type A: chronic pain clinical trials
Registry records that list "Drug: Botulinum toxin type A" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
6
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
6 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Botulinum Toxin for Chronic Neuropathic Pain NCT06036043 | Unknown status | Denmark | Region Zealand | 2023-08-01 | |
| BTA vs Baclofen for Pelvic Myofascial Pain Syndrome NCT05617118 | Unknown status | Russia | Saint Petersburg State University, Russia | 2022-12-01 | |
| Evaluation of Botox Treatment on Chronical Scrotal Pain NCT05112081 | Unknown status | Phase 4 | Denmark | Nicolai Skov Schiellerup | 2022-06-01 |
| (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist NCT03381261 | Completed | Phase 4 | United States | Massachusetts General Hospital | 2017-12-01 |
| Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome NCT00464373 | Terminated | Phase 3 | Switzerland | Daniel Stephan Engeler | 2007-04 |
| Intra-articularInjection of Botulinum Toxin Type NCT00211679 | Unknown status | Phase 2 | United States | Minneapolis Veterans Affairs Medical Center | 2004-06 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.